Discoverant Software System Implemented at Genzyme Site in Geel, Belgium
January 20, 2009
Lafayette, Colo. – Jan. 20, 2009 – Aegis Analytical Corp., a leading provider of Manufacturing Process Intelligence software, announced today that Genzyme, one of the world’s leading biotechnology companies, has deployed Aegis’ Discoverant data management and analytics solution at its Geel, Belgium, manufacturing facility.
The operation at Geel is a state-of-the-art cell culture production facility for therapeutic proteins and is among the largest bio-manufacturing sites in Europe.
“With the implementation of Discoverant, Genzyme will enhance its production capabilities and support the commercial release of its unique therapies to market,” said Robert Di Scipio, Aegis president and CEO.
Discoverant is an off-the-shelf product specifically designed to help manage pharmaceutical and biopharmaceutical manufacturing processes. It enables on-demand access to, and correlation of, data in disparate product data sources, such as paper records, manufacturing execution systems (MES), laboratory information management systems (LIMS), Oracle databases and data warehouses in one validatable environment. Discoverant helps provide process understanding which increases process predictability, reduces process start-up risks, improves product quality, decreases cycle time and assures compliance within good manufacturing practices (GMP) and Food and Drug Administration (FDA)-regulated production and packaging environments.
“In the life science industry, where process predictability and time to value are paramount, we see companies successfully using Discoverant to accelerate time to market by enabling the technology transfer from development into commercial manufacturing,” commented Hussain Mooraj, AMR Research’s vice president, healthcare & life sciences.
About Genzyme
One of the world’s leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenue of $3.8 billion. In 2008, an independent survey commissioned by the journal Science ranked Genzyme third among nearly 500 companies citing it as one of the top life-science employers of scientists in the biotechnology and pharmaceutical industries.
With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company’s products and services are focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial development program focusing on these fields, as well as immune disease, infections disease, and other areas of unmet medical needs.
About Aegis Analytical Corporation
Aegis provides Manufacturing Intelligence solutions that drive a lean supply chain and accelerate revenue with a proven approach to data access, aggregation, analytics and reporting. The company’s enterprise-class software platform, Discoverant®, leverages existing IT investments to enable on-demand and scheduled access to all manufacturing, quality and process development data for process performance analysis and visibility. Leading manufacturers increase profits by using Discoverant to improve process predictability, quality and yield and accelerate technology transfer. To learn more about Discoverant, visit: www.aegiscorp.com.
# # #
Contact:
Lisa Fairbanks
Aegis Analytical Corp.
303-625-2130